Anbio Biotechnology (NNNN)
$5.67 -0.10 (-1.73%)Market Cap | N/A |
Revenue (ttm) | 6.71M |
Net Income (ttm) | 2.25M |
EPS (ttm) | N/A |
PE Ratio | N/A |
Forward PE | N/A |
Profit Margin | 33.58% |
Debt to Equity Ratio | N/A |
Volume | 395,500 |
Avg Vol | N/A |
Day's Range | N/A - N/A |
Shares Out | N/A |
Stochastic %K | N/A |
Beta | N/A |
Analysts | Strong Buy |
Price Target | N/A |
Latest News on NNNN


Feb 20, 2025, 9:50 AM EST - 6 weeks ago
Anbio Biotechnology Announces Closing of Initial Public Offering

Feb 18, 2025, 6:10 PM EST - 6 weeks ago
Anbio Biotechnology Announces Pricing of Initial Public Offering


Jan 2, 2025, 12:06 PM EST - 3 months ago
Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch